These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 17222353)

  • 21. Long-term outcome of isolated coronary artery bypass surgery in patients with severe left ventricular dysfunction.
    Appoo J; Norris C; Merali S; Graham MM; Koshal A; Knudtson ML; Ghali WA
    Circulation; 2004 Sep; 110(11 Suppl 1):II13-7. PubMed ID: 15364831
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Time dependence of defibrillator benefit after coronary revascularization in the Multicenter Automatic Defibrillator Implantation Trial (MADIT)-II.
    Goldenberg I; Moss AJ; McNitt S; Zareba W; Hall WJ; Andrews ML; Wilber DJ; Klein HU;
    J Am Coll Cardiol; 2006 May; 47(9):1811-7. PubMed ID: 16682305
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prophylactic use of implanted cardiac defibrillators in patients at high risk for ventricular arrhythmias after coronary-artery bypass graft surgery. Coronary Artery Bypass Graft (CABG) Patch Trial Investigators.
    Bigger JT
    N Engl J Med; 1997 Nov; 337(22):1569-75. PubMed ID: 9371853
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Early and midterm outcome after off-pump coronary artery bypass grafting in patients with left ventricular dysfunction.
    Toumpoulis IK; Anagnostopoulos CE; DeRose JJ; Swistel DG
    Heart Surg Forum; 2004; 7(6):E539-45; discussion E539-45. PubMed ID: 15769682
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prophylactic implantable cardioverter defibrillator therapy in dilated cardiomyopathy: impact of left ventricular function.
    Schaer BA; Ammann P; Sticherling C; Zellweger MJ; Cron TA; Osswald S
    Int J Cardiol; 2006 Mar; 108(1):26-30. PubMed ID: 16516695
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Implantable cardioverter-defibrillator efficacy in patients with heart failure and left ventricular dysfunction (from the MADIT II population).
    Zareba W; Piotrowicz K; McNitt S; Moss AJ;
    Am J Cardiol; 2005 Jun; 95(12):1487-91. PubMed ID: 15950580
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Aminoterminal B-type pro-natriuretic peptide as a marker of recovery after high-risk coronary artery bypass grafting in patients with ischemic heart disease and severe impaired left ventricular function.
    Rothenburger M; Stypmann J; Bruch C; Wichter T; Hoppe M; Drees G; Berendes E; Huelsken G; Loeher A; Welp H; Röttger C; Schmid C; Scheld HH; Tjan TD
    J Heart Lung Transplant; 2006 May; 25(5):596-602. PubMed ID: 16678040
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The cost-effectiveness of primary prophylactic implantable defibrillator therapy in patients with ischaemic or non-ischaemic heart disease: a European analysis.
    Smith T; Jordaens L; Theuns DA; van Dessel PF; Wilde AA; Hunink MG
    Eur Heart J; 2013 Jan; 34(3):211-9. PubMed ID: 22584647
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Predictors of immediate and long-term outcomes of coronary bypass surgery in patients with left ventricular dysfunction.
    Gatti G; Maschietto L; Dell'Angela L; Benussi B; Forti G; Dreas L; Soso P; Russo M; Sinagra G; Pappalardo A
    Heart Vessels; 2016 Jul; 31(7):1045-55. PubMed ID: 26174428
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Aortocoronary bypass in severe left ventricular dysfunction: 9 years of clinical experience and mid-term results].
    Nardi P; De Paulis R; Penta de Peppo A; Forlani S; Tomai F; Scafuri A; Pellegrino A; Polisca P; Chiariello L
    Ital Heart J Suppl; 2001 Aug; 2(8):894-9. PubMed ID: 11582722
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MADIT II, the Multi-center Autonomic Defibrillator Implantation Trial II stopped early for mortality reduction, has ICD therapy earned its evidence-based credentials?
    Coats AJ
    Int J Cardiol; 2002 Jan; 82(1):1-5. PubMed ID: 11786150
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term follow up of patients with implantable cardioverter-defibrillators and mild, moderate, or severe impairment of left ventricular function.
    Trappe HJ; Wenzlaff P; Pfitzner P; Fieguth HG
    Heart; 1997 Sep; 78(3):243-9. PubMed ID: 9391285
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Surgical aspects of a randomized trial of defibrillator implantation during coronary artery bypass surgery. The CABG Patch Trial.
    Spotnitz HM; Herre JM; Baker LD; Fitzgerald DM; Kron IL; Bigger JT
    Circulation; 1996 Nov; 94(9 Suppl):II248-53. PubMed ID: 8901755
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of left ventricular ejection fraction on occurrence of ventricular events in defibrillator patients with coronary artery disease.
    Schaer B; Sticherling C; Szili-Torok T; Osswald S; Jordaens L; Theuns DA
    Europace; 2011 Nov; 13(11):1562-7. PubMed ID: 21712284
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of implantable cardioverter-defibrillator implantation on surgical morbidity in the CABG Patch Trial. Surgical Investigators of the Coronary Artery Bypass Graft Patch Trial.
    Spotnitz HM; Herre JM; Raza ST; Hammon JW; Baker LD; Fitzgerald DM; Kron IL; Bigger JT
    Circulation; 1998 Nov; 98(19 Suppl):II77-80. PubMed ID: 9852885
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Percutaneous coronary intervention among patients with left ventricular systolic dysfunction: a review and meta-analysis of 19 clinical studies.
    Kunadian V; Pugh A; Zaman AG; Qiu W
    Coron Artery Dis; 2012 Nov; 23(7):469-79. PubMed ID: 22960383
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Implantable cardioverter defibrillator therapy for patients with less severe left ventricular dysfunction.
    Exner DV
    Curr Opin Cardiol; 2009 Jan; 24(1):61-7. PubMed ID: 19077818
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Coronary artery bypass grafting in patients with severe left ventricular dysfunction--early and mid-term outcomes.
    Shapira OM; Hunter CT; Anter E; Bao Y; DeAndrade K; Lazar HL; Shemin RJ
    J Card Surg; 2006; 21(3):225-32. PubMed ID: 16684046
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of Coronary Artery Bypass Grafting on Left Ventricular Ejection Fraction in Men Eligible for Implantable Cardioverter-Defibrillator.
    Vakil K; Florea V; Koene R; Kealhofer JV; Anand I; Adabag S
    Am J Cardiol; 2016 Mar; 117(6):957-60. PubMed ID: 26803382
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The relationship between left ventricular scar and ventricular repolarization in patients with coronary artery disease: insights from late gadolinium enhancement magnetic resonance imaging.
    Scott PA; Rosengarten JA; Shahed A; Yue AM; Murday DC; Roberts PR; Peebles CR; Harden SP; Curzen NP; Morgan JM
    Europace; 2013 Jun; 15(6):899-906. PubMed ID: 23143860
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.